
Monash University
Brings real-world examples to learning.
Inspires students to reach new heights.
Creates dynamic and engaging lessons.
Makes complex topics easy to understand.
Always positive and motivating in class.
Professor Richard Stark is a distinguished neurologist and academic based at Monash University in Melbourne, Australia. With a career spanning clinical practice, research, and education, he has made significant contributions to the field of neurology, particularly in the study and management of headaches and migraines. His work bridges clinical expertise with academic rigor, earning him recognition as a leading figure in his discipline.
Professor Stark holds advanced medical qualifications in neurology. While specific details of his degrees and conferring institutions are not fully detailed in public sources, he is widely recognized as a qualified medical practitioner and specialist neurologist, with credentials that align with his senior academic and clinical roles at Monash University and affiliated hospitals.
Professor Stark’s primary research interests lie in the field of headache disorders, including migraine and cluster headache. His work focuses on improving diagnosis, treatment strategies, and patient outcomes through evidence-based approaches. He is also involved in clinical trials and studies aimed at understanding the mechanisms of neurological conditions, contributing to both national and international guidelines for headache management.
Professor Stark has authored numerous peer-reviewed articles and contributed to clinical guidelines in the field of neurology. Below is a selection of notable works based on publicly available data:
Professor Stark has had a profound impact on the field of neurology, particularly in the area of headache management. His research and clinical guidelines have influenced treatment protocols in Australia and beyond, improving patient care standards. As an educator at Monash University, he has shaped the next generation of neurologists through his teaching and mentorship. His involvement in clinical trials has also contributed to advancing therapeutic options for chronic neurological conditions.